Daily news email for July 26, 2010 | Click here for updated news
BioSpace Pfizer Animal Health Recalls Animal Drug, Terramycin
Dr. Reddy's Laboratories Ltd.'s Rules Out Stake Sale to GlaxoSmithKline
FDA Grants Biovest International, Inc. Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID(R), Targeting Mantle Cell Lymphoma
Johnson & Johnson's HIV Drug Rilpivirine Passes Phase III Trials but Stumbles on Virologic Failure
'Sleep Control' Cells Allow Blind Mice To See, Johns Hopkins University Study
|
BioSpace - Breaking News Gilead Sciences, Inc. to Offer $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock
XenoPort, Inc. Announces Presentation of Preclinical Data for Acamprosate Prodrug at Syndrome Conference
Federal Government Seizes Cyanide Antidote Kits From California Company, Keystone Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited Comments on Generic Lovenox(R) Approval
BHR Pharma, LLC Enrolls First Patient in Phase 3 SyNAPSe Traumatic Brain Injury Trial
|
Biotech News - Business Wire NHS Choices: Five Drinking Myths
Research and Markets: Indian In-vitro Diagnostics Market Report - Proliferation of Lifestyle Diseases Revs up Prospects for the Indian In-vitro Diagnostics Market
Rodman & Renshaw Announces Analyst Discussion with PolyMedix, Inc.
BrainStorm Retains Life Sciences Advisory Firm
PetroAlgae Signs Offtake Agreement for BioCrude with Korea-Based Eco-Frontier
|